These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28903888)

  • 1. Serum Angiogenic and Anti-angiogenic Markers in Pregnant Women with Placenta Percreta.
    Uyanıkoğlu H; İncebıyık A; Turp AB; Çakmak G; Sak S; Hilali NG
    Balkan Med J; 2018 Jan; 35(1):55-60. PubMed ID: 28903888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
    Holme AM; Roland MC; Henriksen T; Michelsen TM
    Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum angiogenic profile in abnormal placentation.
    Biberoglu E; Kirbas A; Daglar K; Biberoglu K; Timur H; Demirtas C; Karabulut E; Danisman N
    J Matern Fetal Neonatal Med; 2016 Oct; 29(19):3193-7. PubMed ID: 26863111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of vascular endothelial growth factor and placenta growth factor for placenta accreta spectrum.
    Faraji A; Akbarzadeh-Jahromi M; Bahrami S; Gharamani S; Raeisi Shahraki H; Kasraeian M; Vafaei H; Zare M; Asadi N
    J Obstet Gynaecol; 2022 Jul; 42(5):900-905. PubMed ID: 34558384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum endothelin-1 and placental alkaline phosphatase levels in placenta percreta and normal pregnancies.
    Uyanikoglu H; Turp AB; Hilali NG; Incebiyik A
    J Matern Fetal Neonatal Med; 2018 Mar; 31(6):777-782. PubMed ID: 28274166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating angiogenic proteins in trisomy 13.
    Bdolah Y; Palomaki GE; Yaron Y; Bdolah-Abram T; Goldman M; Levine RJ; Sachs BP; Haddow JE; Karumanchi SA
    Am J Obstet Gynecol; 2006 Jan; 194(1):239-45. PubMed ID: 16389038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of imminent preeclampsia at 35-37 weeks gestation.
    Ciobanu A; Wright A; Panaitescu A; Syngelaki A; Wright D; Nicolaides KH
    Am J Obstet Gynecol; 2019 Jun; 220(6):584.e1-584.e11. PubMed ID: 30738886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early pregnancy angiogenic markers and spontaneous abortion: an Odense Child Cohort study.
    Andersen LB; Dechend R; Karumanchi SA; Nielsen J; Joergensen JS; Jensen TK; Christesen HT
    Am J Obstet Gynecol; 2016 Nov; 215(5):594.e1-594.e11. PubMed ID: 27287686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accreta complicating complete placenta previa is characterized by reduced systemic levels of vascular endothelial growth factor and by epithelial-to-mesenchymal transition of the invasive trophoblast.
    Wehrum MJ; Buhimschi IA; Salafia C; Thung S; Bahtiyar MO; Werner EF; Campbell KH; Laky C; Sfakianaki AK; Zhao G; Funai EF; Buhimschi CS
    Am J Obstet Gynecol; 2011 May; 204(5):411.e1-411.e11. PubMed ID: 21316642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does soluble fms-like tyrosine kinase-1 regulate placental invasion? Insight from the invasive placenta.
    McMahon K; Karumanchi SA; Stillman IE; Cummings P; Patton D; Easterling T
    Am J Obstet Gynecol; 2014 Jan; 210(1):68.e1-4. PubMed ID: 23994221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating angiogenic factors in preeclampsia, gestational proteinuria, and preeclampsia superimposed on chronic glomerulonephritis.
    Masuyama H; Suwaki N; Nakatsukasa H; Masumoto A; Tateishi Y; Hiramatrsu Y
    Am J Obstet Gynecol; 2006 Feb; 194(2):551-6. PubMed ID: 16458660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences and similarities in endothelial and angiogenic profiles of preeclampsia and COVID-19 in pregnancy.
    Palomo M; Youssef L; Ramos A; Torramade-Moix S; Moreno-Castaño AB; Martinez-Sanchez J; Bonastre L; Pino M; Gomez-Ramirez P; Martin L; Garcia Mateos E; Sanchez P; Fernandez S; Crovetto F; Escolar G; Carreras E; Castro P; Gratacos E; Crispi F; Diaz-Ricart M
    Am J Obstet Gynecol; 2022 Aug; 227(2):277.e1-277.e16. PubMed ID: 35351411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential plasma angiogenic factors levels in women with suspected preeclampsia.
    Baltajian K; Bajracharya S; Salahuddin S; Berg AH; Geahchan C; Wenger JB; Thadhani R; Karumanchi SA; Rana S
    Am J Obstet Gynecol; 2016 Jul; 215(1):89.e1-89.e10. PubMed ID: 26827880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia.
    Khalil A; Maiz N; Garcia-Mandujano R; Penco JM; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Mar; 47(3):324-31. PubMed ID: 26387758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-trimester serum soluble fms-like tyrosine kinase-1, free vascular endothelial growth factor, placental growth factor and uterine artery Doppler in preeclampsia.
    Odibo AO; Rada CC; Cahill AG; Goetzinger KR; Tuuli MG; Odibo L; Macones GA; England SK
    J Perinatol; 2013 Sep; 33(9):670-4. PubMed ID: 23558430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical value of serum VEGF and sFlt-1 in pernicious placenta previa.
    Wang N; Shi D; Li N; Qi H
    Ann Med; 2021 Dec; 53(1):2041-2049. PubMed ID: 34927512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating soluble fms-like tyrosine kinase-1 and placental growth factor from 10 to 40 weeks' pregnancy in normotensive women.
    Wataganara T; Pratumvinit B; Lahfahroengron P; Pooliam J; Talungchit P; Leetheeragul J; Sukpanichnant S
    J Perinat Med; 2017 Oct; 45(7):895-901. PubMed ID: 28665791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin elevates circulating soluble fms-like tyrosine kinase-1 immunoreactivity in pregnant women receiving anticoagulation therapy.
    Rosenberg VA; Buhimschi IA; Lockwood CJ; Paidas MJ; Dulay AT; Ramma W; Abdel-Razeq SS; Zhao G; Ahmad S; Ahmed A; Buhimschi CS
    Circulation; 2011 Dec; 124(23):2543-53. PubMed ID: 22082677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.
    Govender N; Naicker T; Rajakumar A; Moodley J
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):100-5. PubMed ID: 23806447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fractional excretion of angiogenic factors in women with severe preeclampsia.
    Buhimschi CS; Magloire L; Funai E; Norwitz ER; Kuczynski E; Martin R; Richman S; Guller S; Lockwood CJ; Buhimschi IA
    Obstet Gynecol; 2006 May; 107(5):1103-13. PubMed ID: 16648417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.